Viewing Study NCT04476459


Ignite Creation Date: 2025-12-24 @ 2:48 PM
Ignite Modification Date: 2025-12-25 @ 11:51 PM
Study NCT ID: NCT04476459
Status: UNKNOWN
Last Update Posted: 2021-03-15
First Post: 2020-07-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL
Sponsor: Huiqiang Huang
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module